Bruker (BRKR) Interest & Investment Income (2010 - 2026)
Bruker's (BRKR) quarterly Interest & Investment Income came in at $11.3 million in Q2 2026, up 318.52% on a YoY basis from $2.7 million in Q2 2025, and up 130.61% quarter-over-quarter from $4.9 million in Q1 2026.
Analysis
Bruker (BRKR) Interest & Investment Income (2010 - 2026) Analysis & Trends
Bruker (BRKR) has reported Interest & Investment Income for 14 consecutive years, with $11.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest & Investment Income rose 318.52% year-over-year to $11.3 million; the trailing twelve-month figure through Jun 2026 stood at $25.2 million (up 149.5% YoY), and the FY2025 full-year result was $14.8 million, up 59.14% from the prior year.
- Interest & Investment Income improved to $11.3 million in Q2 2026 per BRKR's latest filing, from $4.9 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $11.3 million in Q2 2026 and bottomed at $400000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $2.8 million across 5 years, with a median of $2.3 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income soared 375.0% in 2023, then slipped 5.0% in 2024.
- Over 5 years, Interest & Investment Income stood at $1.1 million in 2022, then jumped by 100.0% to $2.2 million in 2023, then gained by 9.09% to $2.4 million in 2024, then jumped by 91.67% to $4.6 million in 2025, then soared by 145.65% to $11.3 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $11.3 million, $4.9 million, and $4.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 224.92 Bn | 220.86 Bn | 8.34 Bn | 207.00 Mn |
| 2 | Danaher | 144.28 Bn | 139.93 Bn | 3.61 Bn | 61.00 Mn |
| 3 | Agilent Technologies | 40.97 Bn | 39.21 Bn | 1.04 Bn | 15.00 Mn |
| 4 | Illumina | 31.40 Bn | 30.23 Bn | 770.00 Mn | 8.00 Mn |
| 5 | Revvity | 13.71 Bn | 12.68 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 1.37 Mn |
| 7 | Bio-Rad Laboratories | 10.08 Bn | 8.46 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.47 Bn | 8.46 Bn | 110.04 Mn | 6.43 Mn |
| 9 | 10x Genomics | 8.71 Bn | 8.16 Bn | 112.50 Mn | 4.80 Mn |
| 10 | Bruker | 8.37 Bn | 8.16 Bn | 416.00 Mn | 11.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.30 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 4.60 Mn |
| Sep 30, 2025 | 4.40 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 3.10 Mn |
| Dec 31, 2024 | 2.40 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 900,000.00 |
| Jun 30, 2022 | 400,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Dec 31, 2019 | 12.80 Mn |
| Sep 30, 2019 | -4.70 Mn |